Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
Latest Events
Latest News
Product & Service
CPhI Japan, Tokyo
Mar. 16-18, 2020
DCAT Week, New York
Mar. 23-26, 2020
Filed US DMF of Gadoterate Meglumine (#034129, date of submission: Sep. 12, 2019) 2019-09-18
Filed CN DMF of Benzonatate (#Y20190000653, date of submission: July 25, 2019) 2019-08-19
Formosa Pharma files IND with US FDA for APP13007, an ophthalmic treatment for post-ocular surgery pain and inflammation 2019-06-10
Passed 7th US FDA inspection, a combined surveillance inspection and PAI for Sevelamer Carbonate and Colesevelam Hydrochloride 2019-02-11
Great Accomplishment of Formosa Labs’ Investment –EirGenix’s Manufacturing Plant Opened in Zhubei, Taiwan 2019-01-23
Active Pharmaceutical Ingredients
Contract Development and Manufacturing Organization (CDMO)
Antibody Drug Conjugates (ADCs)
UV Filters



 
Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.
丙肝